Literature DB >> 2932156

Second-derivative infrared spectroscopic studies of the secondary structures of bacteriorhodopsin and Ca2+-ATPase.

D C Lee, J A Hayward, C J Restall, D Chapman.   

Abstract

The resolution of minor amide components in the infrared spectra of membrane proteins has, in the past, been limited by the small differences in frequency compared to the large half-widths of the bands that are assigned to different secondary conformations. Here, second-derivative calculations are used to resolve the relatively weak bands that are associated with the beta-sheet conformation and the vibrations of some amino acid side chains in the infrared spectra of bacteriorhodopsin and Ca2+-activated adenosine-5'-triphosphatase (Ca2+-ATPase). The spectra presented indicate that bacteriorhodopsin in the purple membrane contains an appreciable amount of beta structure in addition to the predominant alpha II-helical structure. Both sarcoplasmic reticulum and purified Ca2+-ATPase in native lipids contain alpha-helical and random coil conformations together with a small amount of beta structure. In 1,2-dimyristoyl-sn-glycero-3-phosphocholine (DMPC) Ca2+-ATPase adopts a secondary conformation similar to that in the sarcoplasmic reticulum, and this structure is unaffected by the phospholipid phase transition. A shift to a predominantly random coil conformation is associated with solubilization of both bacteriorhodopsin and Ca2+-ATPase in 20% Triton X-100. Second-derivative analysis of the carbonyl stretching vibrations of DMPC bilayers indicates that below the phase-transition temperature (Tm) both bacteriorhodopsin and Ca2+-ATPase perturb the interface region such that the sn-2 carbonyls adopt a conformation similar to the sn-1 carbonyls. Above Tm, these integral proteins have no effect on the static order of the interface region, and the conformational inequivalence of the sn-1 and sn-2 carbonyls is similar to that found in a pure lipid bilayer.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2932156     DOI: 10.1021/bi00337a018

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

Review 1.  FTIR difference spectroscopy of bacteriorhodopsin: toward a molecular model.

Authors:  K J Rothschild
Journal:  J Bioenerg Biomembr       Date:  1992-04       Impact factor: 2.945

2.  Fourier transform infrared evidence for a predominantly alpha-helical structure of the membrane bound channel forming COOH-terminal peptide of colicin E1.

Authors:  P Rath; O Bousché; A R Merrill; W A Cramer; K J Rothschild
Journal:  Biophys J       Date:  1991-03       Impact factor: 4.033

3.  Effect of membrane potential on the conformation of bacteriorhodopsin reconstituted in lipid vesicles.

Authors:  V Brumfeld; I R Miller
Journal:  Biophys J       Date:  1988-10       Impact factor: 4.033

4.  The 32kDa enamelin undergoes conformational transitions upon calcium binding.

Authors:  Daming Fan; Rajamani Lakshminarayanan; Janet Moradian-Oldak
Journal:  J Struct Biol       Date:  2008-04-24       Impact factor: 2.867

5.  Polarized Fourier transform infrared spectroscopy of bacteriorhodopsin. Transmembrane alpha helices are resistant to hydrogen/deuterium exchange.

Authors:  T N Earnest; J Herzfeld; K J Rothschild
Journal:  Biophys J       Date:  1990-12       Impact factor: 4.033

6.  Obtaining information about protein secondary structures in aqueous solution using Fourier transform IR spectroscopy.

Authors:  Huayan Yang; Shouning Yang; Jilie Kong; Aichun Dong; Shaoning Yu
Journal:  Nat Protoc       Date:  2015-02-05       Impact factor: 13.491

7.  Correlation of phospholipid structure with functional effects on the nicotinic acetylcholine receptor. A modulatory role for phosphatidic acid.

Authors:  A Bhushan; M G McNamee
Journal:  Biophys J       Date:  1993-03       Impact factor: 4.033

8.  A new criterion to evaluate water vapor interference in protein secondary structural analysis by FTIR spectroscopy.

Authors:  Ye Zou; Gang Ma
Journal:  Int J Mol Sci       Date:  2014-06-04       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.